Logo image of NLS

NAUTILUS INC (NLS) Stock Fundamental Analysis

NYSE:NLS - New York Stock Exchange, Inc. - US63910B1026 - Common Stock - Currency: USD

0.8204  +0.08 (+11.2%)

After market: 0.85 +0.03 (+3.61%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NLS. NLS was compared to 31 industry peers in the Leisure Products industry. The financial health of NLS is average, but there are quite some concerns on its profitability. NLS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NLS has reported negative net income.
In the past year NLS had a positive cash flow from operations.
In multiple years NLS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: NLS reported negative operating cash flow in multiple years.
NLS Yearly Net Income VS EBIT VS OCF VS FCFNLS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M -100M

1.2 Ratios

The Return On Assets of NLS (-35.77%) is worse than 79.41% of its industry peers.
NLS has a Return On Equity of -84.89%. This is in the lower half of the industry: NLS underperforms 76.47% of its industry peers.
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROIC N/A
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
NLS Yearly ROA, ROE, ROICNLS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50 -100 -150

1.3 Margins

NLS has a Gross Margin of 19.60%. This is amonst the worse of the industry: NLS underperforms 88.24% of its industry peers.
NLS's Gross Margin has declined in the last couple of years.
NLS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.28%
GM growth 5Y-18.44%
NLS Yearly Profit, Operating, Gross MarginsNLS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40

More info and screens

4

2. Health

2.1 Basic Checks

NLS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NLS has been increased compared to 1 year ago.
Compared to 5 years ago, NLS has more shares outstanding
NLS has a worse debt/assets ratio than last year.
NLS Yearly Shares OutstandingNLS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
NLS Yearly Total Debt VS Total AssetsNLS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

2.2 Solvency

An Altman-Z score of 1.84 indicates that NLS is not a great score, but indicates only limited risk for bankruptcy at the moment.
NLS has a Altman-Z score of 1.84. This is in the lower half of the industry: NLS underperforms 61.76% of its industry peers.
NLS has a debt to FCF ratio of 1.35. This is a very positive value and a sign of high solvency as it would only need 1.35 years to pay back of all of its debts.
NLS has a Debt to FCF ratio of 1.35. This is in the better half of the industry: NLS outperforms 70.59% of its industry peers.
A Debt/Equity ratio of 0.24 indicates that NLS is not too dependend on debt financing.
The Debt to Equity ratio of NLS (0.24) is better than 61.76% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.35
Altman-Z 1.84
ROIC/WACCN/A
WACC11.43%
NLS Yearly LT Debt VS Equity VS FCFNLS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M -50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.99 indicates that NLS should not have too much problems paying its short term obligations.
NLS has a Current ratio (1.99) which is in line with its industry peers.
A Quick Ratio of 1.08 indicates that NLS should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.08, NLS is in line with its industry, outperforming 44.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.08
NLS Yearly Current Assets VS Current LiabilitesNLS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 47.92% over the past year.
Looking at the last year, NLS shows a very negative growth in Revenue. The Revenue has decreased by -40.47% in the last year.
The Revenue has been decreasing by -6.73% on average over the past years.
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.19%
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.73%
Sales Q2Q%-23.84%

3.2 Future

Based on estimates for the next years, NLS will show a very strong growth in Earnings Per Share. The EPS will grow by 35.62% on average per year.
The Revenue is expected to grow by 5.08% on average over the next years.
EPS Next Y80.64%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1.27%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NLS Yearly Revenue VS EstimatesNLS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NLS Yearly EPS VS EstimatesNLS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2 -2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

NLS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NLS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NLS Price Earnings VS Forward Price EarningsNLS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

97.06% of the companies in the same industry are more expensive than NLS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.42
EV/EBITDA N/A
NLS Per share dataNLS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

NLS's earnings are expected to grow with 35.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.62%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NLS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NAUTILUS INC

NYSE:NLS (10/31/2023, 8:26:50 PM)

After market: 0.85 +0.03 (+3.61%)

0.8204

+0.08 (+11.2%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryLeisure Products
Earnings (Last)08-09 2023-08-09/amc
Earnings (Next)11-08 2023-11-08/amc
Inst Owners0%
Inst Owner Change0%
Ins Owners3.88%
Ins Owner Change0%
Market Cap29.14M
Analysts74.29
Price Target2.04 (148.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.3
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)31.45%
Min EPS beat(2)-3.09%
Max EPS beat(2)65.99%
EPS beat(4)2
Avg EPS beat(4)13.84%
Min EPS beat(4)-26.01%
Max EPS beat(4)65.99%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.4%
Min Revenue beat(2)-7.9%
Max Revenue beat(2)18.71%
Revenue beat(4)1
Avg Revenue beat(4)-0.49%
Min Revenue beat(4)-7.9%
Max Revenue beat(4)18.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.19%
EPS NY rev (1m)0%
EPS NY rev (3m)29.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.79%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.11
P/FCF 2.42
P/OCF 1.3
P/B 0.49
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)-1.5
EYN/A
EPS(NY)-0.53
Fwd EYN/A
FCF(TTM)0.34
FCFY41.34%
OCF(TTM)0.63
OCFY77.09%
SpS7.71
BVpS1.66
TBVpS1.58
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -35.77%
ROE -84.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.6%
FCFM 4.4%
ROA(3y)-17.6%
ROA(5y)-18.09%
ROE(3y)-48.86%
ROE(5y)-48.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.28%
GM growth 5Y-18.44%
F-Score4
Asset Turnover1.95
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF 1.35
Debt/EBITDA N/A
Cap/Depr 87.18%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.08
Altman-Z 1.84
F-Score4
WACC11.43%
ROIC/WACCN/A
Cap/Depr(3y)122.77%
Cap/Depr(5y)113.7%
Cap/Sales(3y)2.79%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.92%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.19%
EPS Next Y80.64%
EPS Next 2Y35.62%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-40.47%
Revenue growth 3Y-2.49%
Revenue growth 5Y-6.73%
Sales Q2Q%-23.84%
Revenue Next Year1.27%
Revenue Next 2Y5.08%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y26.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year92.9%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y126.3%
FCF growth 3YN/A
FCF growth 5Y-27.55%
OCF growth 1Y148.88%
OCF growth 3YN/A
OCF growth 5Y-11.65%